New class of anti-cancer drug effective against kidney cancer
Metastatic kidney cancer remains largely incurable. Despite a dozen treatments and several immunotherapies, survival rates beyond 5 years remain around 10 percent. A study published in the Journal of Clinical Oncology reports ...
Dec 21, 2017